IRF1-IN-2, CAS [[708245-32-3]]

Produktübersicht

• Artikelname: IRF1-IN-2, CAS [[708245-32-3]]
• Artikelnummer: MCE-HY-171007
• Hersteller Artikelnummer: HY-171007
• Alternativnummer: MCE-HY-171007-10MG,MCE-HY-171007-50MG,MCE-HY-171007-10MMX1ML,MCE-HY-171007-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

IRF1-IN-2 (Compound I-19) is an IRF1 inhibitor. IRF1-IN-2 decreases the recruitment of IRF1 to the promoter of CASP1. IRF1-IN-2 inhibits cell death signaling pathway (i.e., cleavage of Caspase 1, GSDMD, IL-1 and PARP1, inhibits the Pho of TKB1, upregulates GPX4 and downregulates FACL4). IRF1-IN-2 has a protective effect on ionizing radiation-induced inflammatory skin injury[1].

Produkteigenschaften

• Molekulargewicht: 360.43
• Reinheit: 99.83
• CAS Nummer: [708245-32-3]
• Formel: C18H20N2O4S
• Target-Kategorie: Caspase,Glutathione Peroxidase,IFNAR,Interleukin Related,PARP,Pyroptosis

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound